There were no significant differences in diabetes history, smoking history, heart rate, lymphocytes, platelets, direct bilirubin, triglycerides, total cholesterol, LDL-C, HDL-C, Apo-B, Apo-A1, homocysteine, D-to-B time, infarct location, number of implanted stents, and tirofiban between the two groups (P > 0.05), as shown in Table 1. This evidence concerns the gene APOA1 and diabetes mellitus.